NVIDIA Opens BioNeMo to Scale Digital Biology for Global Biopharma and Scientific Industry
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to NVIDIA Opens BioNeMo to Scale Digital Biology for Global Biopharma and Scientific Industry
November 20, 2024 8:55 AM EST
Lynx Equity on 'NVIDIA (NASDAQ: NVDA): 'investors may step aside and look for a better point of entry'
The analyst comments "NVDA stock traded up ~20% since early October when the CEO started a media/Street campaign to message that Blackwell demand is insane and that everythings on track. With the stock close to its all-time high, we detect investor nervousness given that the valuation is leveraged to Blackwell, a future product cycle that has had trouble getting off the starting block due to well-known heating issues. We will wait for an update from management... More
November 19, 2024 6:03 AM EST
Truist Securities analyst William Stein raised the price target on NVIDIA (NASDAQ: NVDA) to $167.00 (from $148.00) while maintaining a Buy rating.
The analyst comments "Buy NVDA into earnings. NVDA reports its CQ3 (Oct.) result on Weds 11/20. We expect NVDA will (1) deliver upside... More
November 19, 2024 5:22 AM EST
Stifel analyst Ruben Roy raised the price target on NVIDIA (NASDAQ: NVDA) to $180.00 (from $165.00) while maintaining a Buy rating.
The analyst comments "NVDA reports its F3Q25 (Oct.) results after market on Wednesday, 11/20. Supply chain data points, as well as discussions with industry... More
